Patents by Inventor Maxime NACHIT

Maxime NACHIT has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12579646
    Abstract: A computer-implemented method for determining a risk of having or developing steatohepatitis and/or a complication thereof in a subject. The method includes the steps of: receiving at least one image of the subject and at least one clinical and/or biological data, both previously obtained from the subject; calculating a score of fat infiltration heterogeneity on the at least one image based on at least one radiomic feature obtained for a region of interest including at least one skeletal muscle; combining the calculated score of fat infiltration heterogeneity with the at least one clinical and/or biological data previously obtained from the subject; determining a risk for the subject of having or developing steatohepatitis and/or a complication thereof based on the combination of the calculated score of fat infiltration heterogeneity with the at least one clinical and/or biological data.
    Type: Grant
    Filed: June 9, 2022
    Date of Patent: March 17, 2026
    Assignee: UNIVERSITÉ CATHOLIQUE DE LOUVAIN
    Inventors: Maxime Nachit, Isabelle Leclercq
  • Publication number: 20240281965
    Abstract: A computer-implemented method for determining a risk of having or developing steatohepatitis and/or a complication thereof in a subject. The method includes the steps of: receiving at least one image of the subject and at least one clinical and/or biological data, both previously obtained from the subject; calculating a score of fat infiltration heterogeneity on the at least one image based on at least one radiomic feature obtained for a region of interest including at least one skeletal muscle; combining the calculated score of fat infiltration heterogeneity with the at least one clinical and/or biological data previously obtained from the subject; determining a risk for the subject of having or developing steatohepatitis and/or a complication thereof based on the combination of the calculated score of fat infiltration heterogeneity with the at least one clinical and/or biological data.
    Type: Application
    Filed: June 9, 2022
    Publication date: August 22, 2024
    Applicant: UNIVERSITÉ CATHOLIQUE DE LOUVAIN
    Inventors: Maxime NACHIT, Isabelle LECLERCQ